Literature DB >> 6843362

Disparate effects of prazosin and propranolol on lipid metabolism in a rat model.

E Dall'Aglio, H Chang, G Reaven.   

Abstract

The effects of 14 days of daily intraperitoneal injections of prazosin hydrochloride (3.0 or 0.3 mg/kg) or propranolol (5 mg/kg) on various aspects of the lipid metabolism of normal rats was studied. The results indicate that plasma triglyceride and cholesterol concentrations were lower and the ratio of plasma HDL-cholesterol to total cholesterol concentration higher in prazosin-treated rats compared with propranolol-treated rats. The decline in plasma triglyceride levels in prazosin-treated rats was associated with a commensurate reduction in triglyceride secretion rates. Plasma free fatty acid levels were also lower in prazosin-treated rats, and this change may have contributed to the fall in triglyceride secretion rates. These data demonstrate that the disparate effects of alpha and beta receptor antagonists, previously shown to occur in hypertensive humans, can be duplicated in normal rats.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6843362     DOI: 10.1016/0026-0495(83)90015-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Effects of dicentrine on haemodynamic, plasma lipid, lipoprotein level and vascular reactivity in hyperlipidaemic rats.

Authors:  S M Yu; Y F Kang; C C Chen; C M Teng
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

2.  Dose-related effects of doxazosin on plasma lipids and aortic fatty streak formation in the hypercholesterolemic hamster model.

Authors:  T L Foxall; G T Shwaery; A F Stucchi; R J Nicolosi; S S Wong
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

3.  Beta-blocker induced changes in the cholesterol: high-density lipoprotein cholesterol ratio and risk of coronary heart disease.

Authors:  B G Woodcock; N Rietbrock
Journal:  Klin Wochenschr       Date:  1984-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.